Status:
UNKNOWN
Progesterone and Doppler in Recurrent Abortion
Lead Sponsor:
Assiut University
Conditions:
Abortion in First Trimester
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
Recurrent pregnancy loss is classically defined as the occurrence of three or more consecutive pregnancy loss. The American Society of Reproductive Medicine has recently redefined recurrent pregnancy ...
Detailed Description
Spontaneous pregnancy loss is a surprisingly common occurrence. Whereas approximately 15% of all clinically recognized pregnancies result in spontaneous loss, there are many more pregnancies that fail...
Eligibility Criteria
Inclusion
- pregnant 7-12 weeks documented by pregnancy test \&/or ultrasaound.
- History of at least 2 prior spontaneous abortion before 12 weeks of gestation.
- Age: 18-35 years
- Willing and able to give informed consent.
- Rh +ve patient
- BMI: 18-32
- Viable pregnancy through the detection of fetal pulsations by ultrasound
- Singleton pregnancy
- Apparently stable pregnancy (no history of vaginal bleeding in this current pregnancy or signs of sac separation in ultrasound)
Exclusion
- Patients diagnosed to have Anti-phospholipid syndrome or another recognised thrombophilic or autoimmune conditions.
- Pregnant \> 12 weeks.
- Contraindication to progesterone use.
- Diabetic patients, have glucose intolerance.
- Multiple pregnancies.
- Thyroid disorder
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 5 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03267771
Start Date
October 1 2017
End Date
December 5 2019
Last Update
September 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gehad Elsherief
Asyut, Egypt